This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
More specifically, the Indian Pharmaceutical Alliance, an organisation representing the country’s largest pharmaceuticalcompanies, has urged the government to reduce import tariffs from the current 10% to zero for pharmaceutical imports from the US. For a demo or further information, please contact us here.
The government therefore is advocating for the creation of the new drug regulatory agency to expedite economic growth, streamline drug approvals and attract international pharmaceuticalcompanies to invest in the country. For a demo or further information, please contact us here.
Prabhakant Sinha, co-founder of ZS Associates, emphasizes that “companies that can think deeply and act swiftly will turn decision velocity into a source of value creation.” 3 One of Fuld’s clients, a global pharmaceuticalcompany, used AI-driven CI to monitor competitor drug launches.
In addition to Ireland, India and China are also major suppliers of active pharmaceutical ingredients to the US, with major contract manufacturing organisations (CMOs) such as WuXi Biologics that have large plants in China. Request a free demo for GlobalData’s Strategic Intelligence here. Sign up for our daily news round-up!
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content